ipilimumab,lefitolimod
bms
['ipilimumab', 'solid tumor']
a phase i clinical trial presented by dr. mirella nardo showed promising results for a combination of lefitolimod and ipilimumab in patients with advanced solid tumors (2564). #asco23 #immunotherapy #endcancer (5/9) 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789